- Conditions
- Parenteral Nutrition Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- Vanderbilt University Medical Center
- Other
- Eligibility
- Up to 24 Months
- Enrollment
- 48 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2019
- U.S. locations
- 1
- States / cities
- Nashville, Tennessee
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–30
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Short Bowel Syndrome, Cholestasis
- Interventions
- Omegaven Therapy
- Drug
- Lead sponsor
- Amarnath, Rathna, M.D.
- Individual
- Eligibility
- Up to 1 Year
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2013
- U.S. locations
- 1
- States / cities
- Columbia, South Carolina
- Conditions
- Total Parenteral Nutrition-induced Cholestasis
- Interventions
- Omegaven IV lipid emulsion
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- Up to 17 Years
- U.S. locations
- 1
- States / cities
- Park Ridge, Illinois
- Conditions
- Cholestasis of Parenteral Nutrition
- Interventions
- Omegaven 10%
- Drug
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 2 Months to 18 Years
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Parenteral Nutrition Associated Liver Disease
- Interventions
- Omegaven
- Drug
- Lead sponsor
- St. Luke's Health System, Boise, Idaho
- Other
- Eligibility
- Up to 17 Years
- U.S. locations
- 1
- States / cities
- Boise, Idaho
- Conditions
- Liver Disease, Short Bowel Syndrome
- Interventions
- Lovaza (omega-3-acid ethyl ester), Corn oil
- Drug · Dietary Supplement
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 30 Days to 21 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts